asia healthspace

Clearstate analysis of interventional cardiology products’ market opportunity in China reveals a huge market set to experience exceptional growth across several product segments over the next few years. The market is expanding in line with a dramatic rise in cardiovascular disease among increasingly affluent and urbanised Chinese, with the resulting surge in demand for high [...]

A recent Clearstate study found nascent but growing demand for platelet aphaeresis in India, driven by disease outbreaks, procedural demand and clinician awareness. Blood banking infrastructure: India maintains a heterogeneous system of blood banks run by government, private hospitals and independent organisations. There are about 2600 blood banks in India. Roughly one-third of all blood [...]

Urology is a rather developed specialization in China with many universities and hospitals’ undertaking extensive research in this field. The level of technological advancement is also increasing with more hospitals now able to do robotic surgery. There are an estimated number of at least 2000 urologists in China, and almost all of them are trained [...]

Asian countries in general and China and India in particular, have been countries of economic interest for the last few years. Economic development has encouraged lifestyle changes which have resulted in a shift in disease prevalence more typically seen in richer Western Countries. With improved sanitation, widespread availability of antibiotics and immunization, there has been [...]

Governments in emerging markets would be wise to learn from the evolution (or lack thereof…) of the health care delivery systems in the developed countries and understand why systems that consume so much in terms of resources can deliver such highly variable patient care outcomes. This exercise will help emerging market countries position themselves for [...]

These are exciting times for the Indian biotechnology industry. The industry has doubled in size within the last two years buoyed by a strong growth in biotech exports. In the year 2006-07, it passed the USD 2 billion mark in revenues and registered a 31% growth rate as compared to the fiscal year of 2005-06. [...]

Medical tourism in Asia is currently generating USD 1.3 billion in revenue and is expected to grow to USD 4.4 billion by 2012, growing at a CAGR of 19%. The major countries competing for medical tourists in Asia are Thailand, Singapore, India and Malaysia. The main attraction for seeking medical treatment in these countries includes [...]